Nutex Health (NASDAQ:NUTX) Upgraded to Buy at Wall Street Zen

Wall Street Zen upgraded shares of Nutex Health (NASDAQ:NUTX) from a hold rating to a buy rating in a research note published on Saturday.

Separately, Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, Nutex Health currently has an average rating of “Moderate Buy” and an average target price of $252.50.

Nutex Health Price Performance

Nutex Health stock opened at $136.66 on Friday. Nutex Health has a one year low of $77.21 and a one year high of $193.07. The business has a fifty day moving average price of $103.89 and a 200-day moving average price of $127.27. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.39. The firm has a market capitalization of $940.36 million, a P/E ratio of 10.56 and a beta of 0.25.

Nutex Health (NASDAQ:NUTX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.The firm had revenue of $216.49 million during the quarter, compared to analyst estimates of $227.80 million.

Institutional Investors Weigh In On Nutex Health

A number of large investors have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC purchased a new stake in Nutex Health during the first quarter valued at about $360,000. Bank of New York Mellon Corp raised its position in Nutex Health by 9.9% during the first quarter. Bank of New York Mellon Corp now owns 21,622 shares of the company’s stock valued at $2,055,000 after purchasing an additional 1,940 shares in the last quarter. SG Americas Securities LLC raised its position in Nutex Health by 3,232.6% during the first quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after purchasing an additional 29,449 shares in the last quarter. World Investment Advisors purchased a new stake in Nutex Health during the fourth quarter valued at about $266,000. Finally, Pacer Advisors Inc. raised its position in Nutex Health by 4.3% during the fourth quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock valued at $5,480,000 after purchasing an additional 1,359 shares in the last quarter. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.